What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies
Top Cited Papers
Open Access
- 1 September 2008
- journal article
- clinical trial
- Published by American Society of Hematology in Blood
- Vol. 112 (5), 1646-1654
- https://doi.org/10.1182/blood-2008-01-130237
Abstract
We performed a retrospective comparison of presenting features, planned treatment, complete remission (CR) rate, and outcome of 321 adolescents and yKeywords
This publication has 33 references indexed in Scilit:
- Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511Blood, 2007
- Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in SwedenCancer, 2006
- Myths and Lessons from the Adult/Pediatric Interface in Acute Lymphoblastic LeukemiaHematology-American Society Hematology Education Program, 2006
- Clinical characteristics, biologic features and outcome for young adult patients with acute lymphoblastic leukaemiaBritish Journal of Haematology, 2005
- Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trialBritish Journal of Haematology, 2005
- Children and adults with acute lymphoblastic leukaemia have similar gene expression profilesEuropean Journal of Haematology, 2005
- Prognosis in childhood and adult acute lymphoblastic leukaemia: a question of maturation?Cancer Treatment Reviews, 2004
- Differences in Outcome in Adolescents With Acute Lymphoblastic Leukemia: A Consequence of Better Regimens? Better Doctors? Both?Journal of Clinical Oncology, 2003
- Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicinLeukemia, 1998
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958